Fees are a weakness here. The strategy's lofty fees are a high hurdle to clear, as it is priced within the highest quintile among peers.
Fidelity Advisor Healthy Future A FAPJX
- NAV / 1-Day Return 12.89 / +0.62 %
- Total Assets 11.2 Mil
-
Adj. Expense Ratio
- Expense Ratio 1.300%
- Distribution Fee Level High
- Share Class Type Front Load
- Category Large Growth
- Investment Style Large Growth
- Min. Initial Investment —
- Status Open
- TTM Yield —
- Turnover 68%
USD | NAV as of Jul 04, 2024 | 1-Day Return as of Jul 04, 2024, 5:18 AM GMT+0
Morningstar’s Analysis FAPJX
Will FAPJX outperform in future?
Get our overall rating based on a fundamental assessment of the pillars below.
People Pillar
Parent Pillar
- Current Portfolio Date
- Equity Holdings —
- Bond Holdings —
- Other Holdings —
- % Assets in Top 10 Holdings 43.6
Top 10 Holdings
|
% Portfolio Weight
|
Market Value USD
|
Sector
|
---|---|---|---|
NVIDIA Corp | 11.04 | 1.2 Mil | Technology |
Procter & Gamble Co | 6.60 | 727,596 | Consumer Defensive |
Thermo Fisher Scientific Inc | 4.35 | 479,375 | Healthcare |
Vertex Pharmaceuticals Inc | 3.77 | 416,181 | Healthcare |
Nestle SA | 3.72 | 409,936 | Consumer Defensive |
Regeneron Pharmaceuticals Inc | 3.50 | 386,183 | Healthcare |
UnitedHealth Group Inc | 2.99 | 329,916 | Healthcare |
L'Oreal SA | 2.82 | 310,968 | Consumer Defensive |
Tesla Inc | 2.48 | 273,353 | Consumer Cyclical |
UCB SA | 2.32 | 255,293 | Healthcare |